1. Academic Validation
  2. TiSe2-mediated sonodynamic and checkpoint blockade combined immunotherapy in hypoxic pancreatic cancer

TiSe2-mediated sonodynamic and checkpoint blockade combined immunotherapy in hypoxic pancreatic cancer

  • J Nanobiotechnology. 2022 Oct 15;20(1):453. doi: 10.1186/s12951-022-01659-4.
Libin Chen 1 2 3 Wang Xue 4 5 Jing Cao 4 5 Shengmin Zhang 1 Yiqing Zeng 4 5 Ling Ma 1 Xuechen Qian 1 Qing Wen 4 5 Yurong Hong 4 5 Zhan Shi 6 7 Youfeng Xu 8
Affiliations

Affiliations

  • 1 Department of Ultrasound in Medicine, Ningbo First Hospital, Ningbo, 315010, People's Republic of China.
  • 2 Tongji University School of Medicine, Shanghai, 200072, People's Republic of China.
  • 3 Department of Ultrasound in Medicine, Ningbo Ninth Hospital, Ningbo, 315032, People's Republic of China.
  • 4 Department of Ultrasound in Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, No.88 Jiefang Road, Shangcheng District, Hangzhou, 310009, People's Republic of China.
  • 5 Research Center of Ultrasound in Medicine and Biomedical Engineering, The Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang University, Hangzhou, 310009, China.
  • 6 Department of Ultrasound in Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, No.88 Jiefang Road, Shangcheng District, Hangzhou, 310009, People's Republic of China. shizhan@zju.edu.cn.
  • 7 Research Center of Ultrasound in Medicine and Biomedical Engineering, The Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang University, Hangzhou, 310009, China. shizhan@zju.edu.cn.
  • 8 Department of Ultrasound in Medicine, Ningbo First Hospital, Ningbo, 315010, People's Republic of China. xuyoufeng2017@163.com.
Abstract

Background: Pancreatic Cancer remains among the most prevalent and aggressive forms of Cancer. While immunotherapeutic treatment strategies have shown some promise in affected patients, the benefits of these interventions have been limited by insufficient tumor infiltration by activated T cells.

Results: Here, Titanium diselenide (TiSe2) nanosheets were synthesized with good stability. When exposed to ultrasound (US), the TiSe2 nanosheets served as a reliable nano-sensitizer capable of inducing large amounts of Reactive Oxygen Species (ROS) mediating sonodynamic therapy (SDT) under hypoxic and normoxic conditions. The tumor-released TAAs induced by TiSe2 nanosheet-mediated SDT promoted immunogenic cell death (ICD) conducive to the maturation of dendritic cells (DCs), and cytokine secretion and the subsequent activation and infiltration of T cells into the tumor. Combining TiSe2-mediated SDT with anti-PD-1 immune checkpoint blockade treatment led to the efficient suppression of the growth of both primary tumor and distant tumor, while simultaneously preventing lung metastasis. These improved immunotherapeutic and anti-metastatic outcomes were associated with activated systematic antitumor immune responses, including the higher levels of DC maturation and cytokine secretion, the increased levels of CD8+ T cells and the decreased levels of Treg cells infiltrated in tumors.

Conclusion: TiSe2 can be used as a sonosensitizer with good efficacy and high safety to mediate efficient SDT. The combination treatment strategy comprised of TiSe2-mediated SDT and PD-1 blockade activate anti-tumor immune responses effectively thorough inducing ICD, resulting in the inhibition the growth and metastasis of tumor. The combination therapy holds promise as a novel immunotherapy-based intervention strategy for pancreatic Cancer patients.

Keywords

Anti-PD-1; DC maturation; Pancreatic cancer; Sonodynamic therapy; TiSe2.

Figures
Products